Read all the latest news articles from the Royal Society of Tropical Medicine and Hygiene
2020 Mahathir Science Award recipient is a thought-leader in TB, HIV/TB and emerging and re-emerging epidemic infections.
The WHO have released interim guidance on "Considerations for implementing mass treatment, active case‐finding and population-based surveys for neglected tropical diseases in the context of the COVID-19 pandemic"
It is with great sadness that the Royal Society of Tropical Medicine and Hygiene (RSTMH) has learned about the passing of Professor Harold Townson (1942-2020).
We’ve invited our Country Ambassadors to reflect on their country’s COVID-19 response. Let’s hear from Dr Kebede Deribe, our Country Ambassador for Ethiopia.
Now more than ever it is evident how important investment and focus on global health is for the health of all of us.
We are excited to announce that there are three vacancies on the RSTMH Board of Trustees, to start in October 2020.
We’ve invited our Country Ambassadors to reflect on their country’s COVID-19 response. Let’s hear from Dr Aybeniz Dadashova, our Country Ambassador for Azerbaijan.
RSTMH online – Presidential Address by Professor David Mabey and our mid-term strategy review
On 26 May 2020 we welcomed over 160 guests to our online event to provide an update on progress on our five-year strategy, launched in 2017.
We’ve invited our Country Ambassadors to reflect on their country’s COVID-19 response. Let’s hear from Dr Rania Baleela, our Country Ambassador for Sudan.
The World Health Organization (WHO) has updated its interim guidance for the implementation of community-based health care programmes, including neglected tropical disease programmes in a new report on 7 May 2020.
This year we have once again seen a record number of applicants for our small grants programme, receiving 932 applications in total.
With over 120 small grants funded in 2020, hlet's take a look at the amazing projects being undertaken by our awardees.
The title “Neglected Tropical Diseases of the Skin or Skin NTDs” is a recent designation that encompasses a group of NTDs that share a common feature, namely that they present with lesions on the surface of the body.
Evidence suggests that microbial infections are associated with the production of specific volatile organic compounds (VOCs), causing the release of distinct odours. This area of research has led to interest in using volatiles as biomarkers of infectious diseases, such as cholera, malaria and now COVID-19.